Status:
COMPLETED
Comparison of Two Techniques of Combination Therapy for Treatment of Obstructive Sleep Apnea (OSA)
Lead Sponsor:
Joseph Adame
Conditions:
Treatment for Obstructive Sleep Apnea
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To study the effects of two combination therapies for patients with obstructive sleep apnea (OSA) who have been both intolerant to Positive Airway Pressure (PAP) therapy and sub-therapeutic to oral ap...
Eligibility Criteria
Inclusion
- Baseline diagnosis AHI \> or = 5 plus ESS . or = 10.
- PAP Intolerance
- Partial Response to oral appliance therapy: AHI \> 5
- Age: \> 18
Exclusion
- History of daily use of alcohol, narcotics or Central Nervous System (CNS) depressants.
- Diagnosis of Central Sleep Apnea
- Pregnancy
- Edentulous
- Prisoners
Key Trial Info
Start Date :
June 8 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 7 2019
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT04029311
Start Date
June 8 2017
End Date
May 7 2019
Last Update
April 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
J. Michael Adame, DDS, PA
Edinburg, Texas, United States, 78539